Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million 0 10.03.2025 06:50 The Hindu Checkpoint stockholders will also receive a contingent value right for up to $0.70 per share on achievement of certain milestone Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
